KPA's official statement on manipulated bio equivalency tests.

The Korea Pharmaceutical Association (KPA) announced an official statement on April 26 over the late KFDA's case report of the bio equivalency test fraud covering that the unfortunate incidence should make a critical momentum for the government drug administration level to be one step upgraded

The statement also emphasized to clarify the KPA's position as saying "the incidence should not in...